In addition to acarbose, other hypoglycemic medications have shown potential in the treatment of PPH including glucagon-like peptide-1 (GLP-1) receptor agonist, dipeptidyl peptidase-4 (DPP-IV) inhibitors, and metformin. This evidence concerns the gene GLP1R and pulmonary arterial hypertension.